Adding crizotinib to radiation therapy may help preserve hearing in patients with NF2
Adding the targeted cancer therapy drug crizotinib to radiation therapy for tumors associated with the genetic disorder neurofibromatosis 2 (NF2) may reduce the hearing damage that can be exacerbated by radiotherapy. A Massachusetts ...
Feb 5, 2018
0
39